These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10504392)

  • 21. Design, synthesis, characterization and in-vivo activity of a novel salmon calcitonin conjugate containing a novel PEG-lipid moiety.
    Cheng W; Lim LY
    J Pharm Pharmacol; 2010 Mar; 62(3):296-304. PubMed ID: 20487211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biological potency of a series of analogues of human calcitonin correlates with their interactions with phospholipids.
    Epand RF; Orlowski RC; Epand RM
    Biopolymers; 2004; 76(3):258-65. PubMed ID: 15148685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulating calcitonin fibrillogenesis: an antiparallel alpha-helical dimer inhibits fibrillation of salmon calcitonin.
    Andreotti G; Motta A
    J Biol Chem; 2004 Feb; 279(8):6364-70. PubMed ID: 14594801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable human calcitonin analogues with high potency on bone together with reduced anorectic and renal actions.
    Uda K; Kobayashi Y; Hisada T; Orlowski RC; Bastian JW; Arnaud CD; Wakabayashi K
    Biol Pharm Bull; 1999 Mar; 22(3):244-52. PubMed ID: 10220278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into interactions between the alpha-helical region of the salmon calcitonin antagonists and the human calcitonin receptor using photoaffinity labeling.
    Pham V; Dong M; Wade JD; Miller LJ; Morton CJ; Ng HL; Parker MW; Sexton PM
    J Biol Chem; 2005 Aug; 280(31):28610-22. PubMed ID: 15929987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced potency of human calcitonin when fibrillation is avoided.
    Cudd A; Arvinte T; Das RE; Chinni C; MacIntyre I
    J Pharm Sci; 1995 Jun; 84(6):717-9. PubMed ID: 7562410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for the C-terminus of calcitonin in aggregation and gel formation: a comparative study of C-terminal fragments of human and salmon calcitonin.
    Moriarty DF; Vagts S; Raleigh DP
    Biochem Biophys Res Commun; 1998 Apr; 245(2):344-8. PubMed ID: 9571152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural determinants of salmon calcitonin bioactivity: the role of the Leu-based amphipathic alpha-helix.
    Andreotti G; Méndez BL; Amodeo P; Morelli MA; Nakamuta H; Motta A
    J Biol Chem; 2006 Aug; 281(34):24193-203. PubMed ID: 16766525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
    Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
    J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mono- and bicyclic analogs of parathyroid hormone-related protein. 2. Conformational analysis of antagonists by CD, NMR, and distance geometry calculations.
    Maretto S; Mammi S; Bissacco E; Peggion E; Bisello A; Rosenblatt M; Chorev M; Mierke DF
    Biochemistry; 1997 Mar; 36(11):3300-7. PubMed ID: 9116008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analogues of human calcitonin. V. Influence of basic amino acids in positions 11, 17 and 24 on hypocalcaemic activity in the rat.
    Maier R; Brugger M; Brückner H; Kamber B; Riniker B; Rittel W
    Acta Endocrinol (Copenh); 1977 May; 85(1):102-8. PubMed ID: 577069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic parathyroid hormone related protein antagonists: lysine 13 to aspartic acid 17 [i to (i + 4)] side chain to side chain lactamization.
    Chorev M; Roubini E; McKee RL; Gibbons SW; Goldman ME; Caulfield MP; Rosenblatt M
    Biochemistry; 1991 Jun; 30(24):5968-74. PubMed ID: 1646005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue.
    Andreotti G; Vitale RM; Avidan-Shpalter C; Amodeo P; Gazit E; Motta A
    J Biol Chem; 2011 Jan; 286(4):2707-18. PubMed ID: 21078667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG.
    Huang R; Vivekanandan S; Brender JR; Abe Y; Naito A; Ramamoorthy A
    J Mol Biol; 2012 Feb; 416(1):108-20. PubMed ID: 22200484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NMR investigations of structural and dynamics features of natively unstructured drug peptide - salmon calcitonin: implication to rational design of potent sCT analogs.
    Rawat A; Kumar D
    J Pept Sci; 2013 Jan; 19(1):33-45. PubMed ID: 23208874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats.
    Bhandari KH; Newa M; Chapman J; Doschak MR
    J Control Release; 2012 Feb; 158(1):44-52. PubMed ID: 22001608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analogues of human calcitonin. II. Influence of modifications in amino acid positions 1, 8 and 22 on hypocalcemic activity in the rat.
    Maier R; Kamber B; Riniker B; Rittel W
    Horm Metab Res; 1975 Nov; 7(6):511-4. PubMed ID: 1213659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR.
    Kamihira M; Naito A; Tuzi S; Nosaka AY; Saitô H
    Protein Sci; 2000 May; 9(5):867-77. PubMed ID: 10850796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and Biological Activity of Human Calcitonin Analogue.
    Yu C; Zhou GM; Li BL; Wu XF; Cui DF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 1999; 31(5):553-557. PubMed ID: 12114969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational flexibility and biological activity of salmon calcitonin.
    Epand RM; Epand RF; Orlowski RC; Seyler JK; Colescott RL
    Biochemistry; 1986 Apr; 25(8):1964-8. PubMed ID: 3707923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.